Oxidants induce alternative splicing of alpha-synuclein: Implications for Parkinson's disease

Free Radic Biol Med. 2010 Feb 1;48(3):377-83. doi: 10.1016/j.freeradbiomed.2009.10.045. Epub 2009 Oct 23.

Abstract

alpha-Synuclein (alpha-syn) is a presynaptic protein that is widely implicated in the pathophysiology of Parkinson's disease (PD). Emerging evidence indicates a strong correlation between alpha-syn aggregation and proteasomal dysfunction as one of the major pathways responsible for destruction of the dopamine neurons. Using parkinsonism mimetics (MPP(+), rotenone) and related oxidants, we have identified an oxidant-induced alternative splicing of alpha-syn mRNA, generating a shorter isoform of alpha-syn with deleted exon-5 (112-syn). This spliced isoform has an altered localization and profoundly inhibits proteasomal function. The generation of 112-syn was suppressed by constitutively active MEK-1 and enhanced by inhibition of the Erk-MAP kinase pathway. Overexpression of 112-syn exacerbated cell death in a human dopaminergic cell line compared to full-length protein. Expression of 112-syn and proteasomal dysfunction were also evident in the substantia nigra and to a lesser extent in striatum, but not in the cortex of MPTP-treated mice. We conclude that oxidant-induced alternative splicing of alpha-syn plays a crucial role in the mechanism of dopamine neuron cell death and thus contributes to PD.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology
  • Adrenergic Agents / pharmacology
  • Alternative Splicing / drug effects*
  • Animals
  • Blotting, Western
  • Cells, Cultured
  • Disease Models, Animal
  • Dopamine Agents / pharmacology
  • Humans
  • Immunoblotting
  • Immunoenzyme Techniques
  • Male
  • Mesencephalon
  • Mice
  • Mice, Inbred C57BL
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism
  • Oxidants / pharmacology*
  • Oxidopamine / pharmacology
  • Parkinson Disease / drug therapy
  • Parkinson Disease / genetics*
  • Parkinson Disease / pathology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Rotenone / pharmacology
  • Substantia Nigra / cytology
  • Substantia Nigra / drug effects
  • Substantia Nigra / metabolism
  • Tyrosine 3-Monooxygenase / metabolism
  • Uncoupling Agents / pharmacology
  • alpha-Synuclein / genetics*
  • alpha-Synuclein / metabolism

Substances

  • Adrenergic Agents
  • Dopamine Agents
  • Oxidants
  • RNA, Messenger
  • Uncoupling Agents
  • alpha-Synuclein
  • Rotenone
  • Oxidopamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Tyrosine 3-Monooxygenase